Protagenic Therapeutics Faces Delisting Concerns
Ticker: PTIXW · Form: 8-K · Filed: May 24, 2024 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | May 24, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $35,000,000, $500,000 m, $2,500,000 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, listing-standards
Related Tickers: PTIX
TL;DR
PTIX might get delisted, check exchange rules.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on May 24, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company was formerly known as Atrinsic, Inc., New Motion, Inc., and MPLC, Inc., with its most recent name change on June 30, 2009.
Why It Matters
This filing indicates potential issues with Protagenic Therapeutics' compliance with stock exchange listing requirements, which could impact its stock's tradability and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to shareholders.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer of the 8-K report
- May 22, 2024 (date) — Date of the earliest event reported
- May 24, 2024 (date) — Filing date of the 8-K report
- Atrinsic, Inc. (company) — Former company name
- New Motion, Inc. (company) — Former company name
- MPLC, Inc. (company) — Former company name
- June 30, 2009 (date) — Date of a former company name change
FAQ
What specific rule or standard has Protagenic Therapeutics, Inc. failed to satisfy?
The filing is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 22, 2024.
What is the filing date of this 8-K report?
The 8-K report was filed on May 24, 2024.
What were some of Protagenic Therapeutics, Inc.'s former company names?
Protagenic Therapeutics, Inc. was formerly known as Atrinsic, Inc., New Motion, Inc., and MPLC, Inc.
What is the Standard Industrial Classification (SIC) code for Protagenic Therapeutics, Inc.?
The SIC code for Protagenic Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 631 words · 3 min read · ~2 pages · Grade level 13.1 · Accepted 2024-05-24 16:36:00
Key Financial Figures
- $35,000,000 — value of listed securities of less than $35,000,000 and annual net income of less than $500
- $500,000 m — ,000 and annual net income of less than $500,000 maintain stockholders' equity of at least
- $2,500,000 — intain stockholders' equity of at least $2,500,000 (the "Stockholders' Equity Requirement"
Filing Documents
- form8-k.htm (8-K) — 43KB
- 0001493152-24-021383.txt ( ) — 256KB
- protageniccom-20240522.xsd (EX-101.SCH) — 4KB
- protageniccom-20240522_def.xml (EX-101.DEF) — 26KB
- protageniccom-20240522_lab.xml (EX-101.LAB) — 36KB
- protageniccom-20240522_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROTAGENIC THERAPEUTICS, INC. Date: May 24, 2024 By: /s/ Alexander K. Arrow Name: Alexander K. Arrow Title: Chief Financial Officer 3